SAN DIEGO, Oct. 31, 2017 /PRNewswire/ -- Orexigen Therapeutics, Inc. (Nasdaq: OREX) will announce corporate and financial results for the third quarter of 2017 on Monday, November 13th after the market closes. Following the announcement, Orexigen will provide a business update and discuss the financial results in a live webcast and conference call at 5:00 p.m. Eastern Time (2:00 p.m. Pacific Time).
The live call may be accessed by phone by calling (800) 708-4539 (domestic) or (847) 619-6396 (international), participant code 45886353. The webcast can be accessed live on the "Investors" section of the Orexigen web site at www.orexigen.com, and will be archived for 14 days following the call.
Orexigen Contact:Jason KeyesChief Financial OfficerOrexigen Therapeutics, Inc. [email protected]
Media Contact: Erika HackmannY&[email protected]
Advertisement
The live call may be accessed by phone by calling (800) 708-4539 (domestic) or (847) 619-6396 (international), participant code 45886353. The webcast can be accessed live on the "Investors" section of the Orexigen web site at www.orexigen.com, and will be archived for 14 days following the call.
Advertisement
Orexigen Contact:Jason KeyesChief Financial OfficerOrexigen Therapeutics, Inc. [email protected]
Media Contact: Erika HackmannY&[email protected]
View original content:http://www.prnewswire.com/news-releases/orexigen-therapeutics-to-provide-business-update-and-discuss-third-quarter-2017-financial-results-on-november-13-2017-300546934.html
SOURCE Orexigen Therapeutics, Inc.
